« Back to Record
Sadones, J., De Greve, J., Neyns, B., Michotte, A., In't Veld, P., Chaskis, C., Sciot, R., Menten, J., Joossens, E. J. R., Strauven, T., D'Hondt, L., Sartenaer, D., Califice, S. F. E. H. S., Bierau, K., & Svensson, C. (2009). MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma. European journal of cancer, 45(1), 146-153. doi:10.1016/j.ejca.2008.09.002
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/187004



